NCT00731562
- Conditions
- Behavior, Bioavailability, Health Behavior, +2 more
- Locations
-
- Pfizer Investigational Site East Grand Forks, Minnesota, United States
- Pfizer Investigational Site Fargo, North Dakota, United States
Clinical trial condition
Smoking Cessation
Explore clinical trials studying Smoking Cessation. Study availability and eligibility vary by location and protocol.
901 public trials
83 recruiting studies
Smoking Cessation trial results
Completed
Multiple Dose, Dose Escalation Study of Varenicline Controlled Release Formulation in Adult Smokers
NCT00527150
- Conditions
- Behavior, Health Behavior, Smoking Cessation
- Locations
-
- Pfizer Investigational Site East Grand Forks, Minnesota, United States
- Pfizer Investigational Site Fargo, North Dakota, United States
NCT01013454
- Conditions
- Behavior, Health Behavior, Smoking Cessation
- Locations
-
- Pfizer Investigational Site Brussels, Belgium
Completed
Message Priming and Enrollment in, and Response to, a Smoking Cessation Program: A Pilot Study
NCT00596882
- Conditions
- Behavior, Chemically-Induced Disorders, Health Behavior, +4 more
- Locations
-
- Transdisciplinary Tobacco Use Research Center Philadelphia, Pennsylvania, United States
NCT00738595
- Conditions
- Behavior, Health Behavior, Smoking Cessation
- Locations
-
- Evotec Study Site 2 Berlin, Germany
- Evotec Study Site 3 Bochum, Germany
- Evotec Study Site 8 Chemnitz, Germany
- Evotec Study Site 4 Dresden, Germany
- Conditions
- Behavior, Health Behavior, Smoking Cessation
- Locations
-
- Pfizer Investigational Site Fargo, North Dakota, United States
Completed
Efficacy and Safety of Rimonabant as an Aid to Smoking Cessation With or Without Nicotine Patch
NCT00458718
- Conditions
- Behavior, Health Behavior, Smoking Cessation
- Locations
-
- Sanofi-Aventis Bridgewater, New Jersey, United States
NCT00432575
- Conditions
- Behavior, Health Behavior, Smoking Cessation, +1 more
- Locations
-
- Sanofi-Aventis Administrative Office Diegem, Belgium
- Sanofi-Aventis Administrative Office Paris, France
- Sanofi-Aventis Administrative Office Berlin, Germany
- Sanofi-Aventis Administrative Office Milan, Italy
Completed
Nicotine Substitute Prescribed at Hourly Intake or ad Libitum for Heavy Smokers Willing to Quit
NCT00861276
- Conditions
- Behavior, Health Behavior, Smoking Cessation
- Locations
-
- Department of Ambulatory Care and Community Medicine Lausanne, Canton of Vaud, Switzerland
NCT00774605
- Conditions
- Behavior, Health Behavior, Smoking Cessation
- Locations
-
- Pfizer Investigational Site New Haven, Connecticut, United States